Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Study Finds Healthcare Professionals Ill-Equipped to Discuss Medical Cannabis with Patients

A recent study from the New York Institute of Technology (NYIT) reveals that many healthcare providers in the U.S. feel they aren’t equipped to talk with patients about medical marijuana. Despite its growing acceptance, many in the medical field report they haven’t received enough education or training to advise patients confidently.

Currently, cannabis is categorized as a Schedule 1 drug in the U.S., meaning it is considered to have a high abuse potential and no recognized medical benefit. However, in 2023, the DHHS recommended moving it to Schedule 3, recognizing its possible use in treating conditions like cancer-related symptoms, infections, neurological issues, and skin disorders.

At present, medical marijuana is legal in 38 states. Of these, 14 have full-scale medical marijuana programs. An additional nine states only permit the use of cannabis products that are low in THC or high in CBD, and only for certain qualifying health conditions. Because of federal regulations, healthcare providers cannot write traditional prescriptions for cannabis. Instead, they may recommend it when patients meet specific criteria, with rules differing significantly from state to state.

Published in Medical Cannabis and Cannabinoids, the NYIT study shows that most doctors, nurses, and other clinical professionals do not feel ready to have informed conversations about cannabis with their patients.

The researchers reviewed 41 separate studies released between 2013 and 2025. These studies included responses from a range of professionals—physicians, trainees, and specialists in various fields—with opinions that often varied depending on their area of practice:

Doctors working in states where medical cannabis is legal, as well as those with more experience, were typically more at ease discussing and recommending it.
A majority of obstetricians were not supportive of its use during pregnancy, and pediatricians were reluctant to support it for children.
Oncologists, primary care doctors, pain specialists, palliative care providers, and emergency physicians generally believe medical marijuana can help treat chronic pain, appetite loss, depression, nausea, and similar issues.
Many physicians felt that marijuana could pose risks to patients with congenital heart conditions.
Neurologists still feel there is social stigma around using cannabis for treating epilepsy.

Lead researcher Dr. Maria Pino, a pharmacist and associate professor, noted that as more states loosen cannabis restrictions, medical professionals need to be better educated. “Training healthcare workers on how to responsibly guide patients using medical marijuana is crucial,” she said. “This not only helps patients get proper care, but also reduces stigma around using cannabis for medical needs.”

The study also pointed out a lack of solid scientific research, which makes it harder to create clear, evidence-based guidelines for medical cannabis treatment.

If healthcare professionals are equipped with the knowledge they need to have informed discussions with patients regarding medical marijuana, the entire cannabis industry, including entities like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) would have valuable allies in helping patients to make informed decisions about using medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Gov. Abbott Calls for Regulation, Vetoes Bill Banning THC in Texas

Texas Governor Greg Abbott has vetoed a measure that aimed at banning all consumable THC products in the state. The move keeps the growing market of THC gummies, vape cartridges, and similar goods open for business. Abbott issued the veto just before the deadline, preventing what would have been one of the strictest THC bans nationwide.

Abbott called on lawmakers to craft tighter regulations for THC products rather than imposing an outright ban. The bill, Senate Bill 3, would have made it a criminal offense to produce, sell, or possess any THC consumables.

The bill followed ongoing efforts in various states to crack down on THC, particularly after the 2018 Farm Bill gave states the power to regulate hemp. Hemp, though non-intoxicating in its natural form, can be synthetically altered to produce THC.

Abbott had not publicly weighed in on the matter while the bill was moving through the legislature, leaving many uncertain about his stance. He explained that the bill likely wouldn’t survive a constitutional test and would clash with existing state and federal laws. He added that pursuing a law destined to be struck down would only delay real solutions to concerns about public safety tied to THC products.

The veto sparked immediate backlash, especially from Lieutenant Gov. Dan Patrick, who had championed the legislation. Patrick had made the THC ban a top priority and had even threatened to push for a special legislative session if it didn’t pass. In a strongly worded statement on social media, Patrick expressed disappointment, citing overwhelming support among Republican lawmakers, law enforcement, educators, and families affected by substance abuse.

Instead of a ban, Abbott is encouraging lawmakers to treat THC products like alcohol—enforcing age restrictions and limiting marketing aimed at minors. Patrick, meanwhile, has planned a press event in Austin to further address the matter.

The legal gray areas in current laws have allowed a thriving THC market to develop, even in states where cannabis remains illegal. Texas has some of the toughest anti-cannabis laws in the U.S., banning recreational use entirely and offering only limited medical access. The hemp industry, however, has created a way for Texans to legally obtain products that offer similar effects to cannabis.

Republican legislators have voiced concerns over the safety of these products, especially given the lack of consistent federal guidelines on manufacturing practices. While Texas has pursued one of the more aggressive approaches to curbing THC sales, other states like California have focused instead on age restrictions and potency limits.

Florida Governor Ron DeSantis vetoed a similar measure last year, stating that it would negatively affect small businesses.

Opponents of the Texas legislation argue that the products provide vital relief for individuals unable to qualify for the state’s narrow medical cannabis program. Business owners across the state also stress that the sector supports thousands of jobs and generates significant revenue.

The marijuana industry, including major brands like SNDL Inc. (NASDAQ: SNDL), hopes that more U.S. jurisdictions that still implement prohibitionist policies against cannabis rethink their stance and create legal markets for the substance so that jobs, state revenue and general livelihoods can be boosted by the legal marijuana business ecosystem.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Firms That Have Weathered the Recent Storms Could Thrive Over the Coming Years

Over the last five years, the marijuana sector has gone through a major shake-up from excessive spending to tough tax burdens and complicated regulations. With all these challenges, a sort of natural selection has taken place: only the most disciplined and resilient companies have survived.

The companies that remain today are generally led by experienced teams who’ve learned to operate with caution and efficiency. The recent downturn has helped reset market expectations, leading to more reasonable valuations.

Unlike previous market peaks in 2019 and 2021, where investors chased rapid expansion and aggressive land grabs, today’s environment favors steady earnings and strong financials. Investors now prioritize capital preservation and want to back businesses that are built to last.

For savvy investors, this presents a window to identify companies with solid leadership, real assets, and operational stability. These are the firms most likely to generate strong, risk-adjusted returns as the market matures.

With valuations down and sellers open to creative deal terms, now could be an ideal time to invest in businesses prepared for the next phase of growth.

Finding the right opportunities in cannabis is still a moving target. This year, investors are showing interest in companies that offer one or more of these advantages: strong consumer brands, distressed assets free from past liabilities, owned real estate or infrastructure, niche market access with little competition, durable market share gains through smart acquisitions, or innovative structures designed to work around federal limitations.

Deals that offer solid downside protection while leaving room for upside are especially appealing. Investors are leaning into structures like convertible notes that offer safety today with equity upside later, preferred equity that ensures priority in returns, and revenue-sharing models that deliver returns through operations rather than relying on uncertain exits.

Some of the most interesting strategies emerging include employee stock ownership plans (ESOPs), which provide liquidity for founders and employees while offering tax perks, and mergers with entities holding large tax losses, which can improve after-tax income when paired with profitable operators.

Policy winds may be shifting as well. For the first time in years, federal cannabis reform seems to be gaining momentum. President Donald Trump has come out in favor of reclassifying cannabis and advancing banking reforms. He’s publicly spoken about the need for more sensible policies that support small businesses and challenge the black market.

If reforms like SAFE Banking or rescheduling move forward, it could spark a return of institutional capital and public market access. That would be a major shift. Over the next one to two years, investors may have a rare chance to get in early on the next wave of cannabis success stories—companies that have already proven their grit and are ready to grow in a more supportive environment.

As that new phase of growth gains steam, plenty of opportunities could be created for companies like Innovative Industrial Properties Inc. (NYSE: IIPR) that address some of the needs of plant-touching companies.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Firms That Have Weathered the Recent Storms Could Thrive Over the Coming Years

As that new phase of growth gains steam, plenty of opportunities could be created for companies like Innovative Industrial Properties Inc. (NYSE: IIPR) that address some of the…

420 with CNW — Marijuana Advocates Express Concerns About the Purchase Rules for Missouri Patients

Medical marijuana advocates are raising concerns about new state guidelines in Missouri that restrict how much cannabis patients can legally buy from dispensaries. Under existing rules, dispensaries must monitor patient purchases to make sure they don’t go over their monthly limits.

Earlier this year, the Missouri Department of Health and Senior Services updated its website with new guidance. It states that once patients hit their allowed amount, they can’t legally switch to recreational purchases to get more marijuana. The department’s cannabis regulation division emphasized that this rule is meant to keep everyone within their legal possession limits.

Currently, patients enrolled in Missouri’s medical cannabis program are limited to 6 ounces of unprocessed cannabis over a 30-day period. Meanwhile, recreational users can buy up to 3 ounces per day, although they’re not allowed to hold more than that at any one time. The law also prohibits tracking purchases of recreational users unless they give consent.

Andrew Mullins, who leads the Missouri Marijuana Trade Association, argued in an April letter that the state’s interpretation of the law isn’t constitutional. He wrote that forcing residents to choose between being medical patients or recreational consumers goes against sound policy and legal principles.

Mullins pointed out that the approach conflicts with what the division told cannabis businesses in 2023, shortly after recreational sales began. At that time, the division had said patients over 21 would also be allowed to make purchases as recreational consumers.

However, department spokesperson Lisa Cox later clarified that the response had been sent in error and did not reflect the finalized rules, which didn’t take effect until August 2023. Cox noted that the department has reviewed Mullins’ concerns and is now reassessing the current policy.

Brennan England, who heads the Missouri chapter of Minorities for Medical Marijuana, says the restrictions hurt communities of color, which were among the earliest to rely on legal medical cannabis for safe and affordable care. England, an advocate and patient himself, launched major reform efforts beginning in 2014 and opened Missouri’s first private cannabis lounge in 2019.

He argues that the current rule not only limits access but also erodes trust in the system. England is calling for a full repeal of the policy, followed by a public dialogue involving patients, business operators, and state regulators. “You can hand out memos,” he said, “but when you sit across from someone whose treatment has been interrupted because of these limits, that’s when real change begins.”

The entire marijuana industry around the country, including leading firms like Green Thumb Industries Inc. (CNX: GTII) (OTCQX: GTBIF), will be watching how the concerns of patients in Missouri will be addressed by the regulators there.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Discussions to Legalize Marijuana Market Reach Pivotal Stage in Pennsylvania

Governor Josh Shapiro and Pennsylvania’s lawmakers are rushing to reach a deal on next year’s budget. With the deadline of July 1 fast approaching, there are still major disagreements over how to cover Shapiro’s proposed spending increases, particularly with a government split between Democrats controlling the House and Republicans holding the Senate.

One of the central goals for the governor and his Democratic allies is to boost funding for public education and transit systems. Republican lawmakers don’t oppose those ideas outright but are more focused on controlling costs, especially rising Medicaid expenses and the widespread use of “skill games”—video gambling machines found in convenience stores, restaurants, and standalone venues.

Shapiro’s spending plan for the FY 2025/26 totals $51.5 billion, marking a 9% increase over the current year. Around $2.5 billion is targeted for Medicaid, partly due to unexpected healthcare costs that arose when individuals remained eligible for Medicaid after the COVID-19 emergency ended. Lawmakers could attempt to delay some of this burden by underestimating costs or deferring payments to hospitals and other providers.

One of the thorniest issues is how to close the projected deficit. Although Shapiro doesn’t propose any hikes to income or sales taxes, his plan leans heavily on reserve funds of $4.5 billion. He is also counting on higher revenue from new tax streams tied to cannabis legalization, changes in corporate taxation, and tighter regulation of skill games. However, all of that depends on legislation still up in the air.

The governor is also proposing an extra $800 million for public schools and universities. Approximately $526 million of this is intended to start complying with a court ruling that said the current school funding formula is unfair to low-income districts. Meanwhile, a separate bill seeks to cut cyber charter school reimbursements, which could save public districts hundreds of millions if it passes the Senate.

Social services providers are also pushing for more money, especially organizations offering home care to Medicaid patients. They’re asking for a 10% ($370 million) bump, citing chronic staff shortages caused by low pay.

Shapiro also wants to boost funding for public transit by $283 million, roughly a 20% jump, to help transit systems recover from pandemic-era ridership declines. Democrats are on board, but Republicans want highway projects to receive comparable attention, possibly funded through revenue from skill game taxes.

The House recently passed a bill to raise the state’s minimum wage above the federal level of $7.25 per hour. Under the proposal, more populated counties would see faster and steeper increases. However, Senate GOP leaders have signaled opposition, casting uncertainty over whether the plan will move forward.

Cannabis industry actors from around the country, such as Curaleaf Holdings Inc. (TSE: CURA) (OTCQX: CURLF), will be hoping that Pennsylvania legalizes marijuana so that residents who wish to consume the substance can legally access it instead of taking risks by resorting to the black market.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana’s Skunky Smell Could Soon Be a Thing of the Past

Not far from the highway, down a stretch near the local sheriff’s station, there’s a high-security facility surrounded by barbed wire. If you happen to drive past, you might catch a sharp, earthy scent in the air, which some call skunky and others say smells like fuel. Either way, it’s unmistakably the scent of cannabis.

The facility is home to District Cannabis, where over 15,000 pounds of marijuana flower are grown annually. Founder and lead cultivator Andras Kirschner proudly calls it their dream “weed factory.” Inside, the air is thick with earthy plant aromas, hints of citrus, and soft floral notes. The familiar strong, skunky odor that used to define marijuana is fading, replaced by sweeter and fruitier profiles as new strains emerge.

According to Pamela Dalton, a Monell Chemical Senses Center smell researcher, the growing popularity of recreational cannabis is pushing the market toward more appealing fragrances. “When people are using it for enjoyment, they want the experience to be pleasant from start to finish,” she explains. This has led to more crossbreeding and new strains with smells that are easier on the nose.

The District Cannabis facility grows thousands of young plants in warm, humid rooms until they’re ready for harvest. Once matured, they’re dried, trimmed, and packaged for sale. Kirschner’s strain, Layer Cake, recently earned top honors in a regional cannabis competition. A related strain called Gelato Cake, also grown on-site, continues to be a strong seller in Maryland and D.C.

Kyle Perrell, operations manager at the facility, says Gelato Cake gives off a complex mix of grape sweetness, a touch of cognac, and a sharp, kerosene-like finish. These layered smells come from terpenes—natural compounds also found in fruits, herbs, and trees. Gelato Cake’s leading terpenes include linalool, caryophyllene, and limonene, which contribute spicy, citrus, and floral notes.

Although many still associate marijuana with that classic skunk smell, new research has identified sulfur compounds as the true source of the strong odor. “We’re extremely sensitive to sulfur,” Dalton says. “Even small amounts can dominate what we smell.” That’s why some strains still hit hard with that pungent scent, even when mixed with more pleasant terpenes.

Each area of the District Cannabis facility carries a signature scent. In one greenhouse, the strain Pavé puts out an intense, earthy, and minty smell. Nearby, in the curing room, Cherry Limeade Cake hangs to dry. Workers in the trimming room carefully shape buds from a new hybrid called Berry Payton, a mix of tropical Runtz and a strain called Gary Payton, filling the air with a blueberry-like scent.

Still, the end goal isn’t just to grow something that smells good. The marijuana grown here goes straight to market, whether as buds, vape oil, edibles, or pre-rolled joints. The facility can produce up to 4 million joints per year, though Kirschner admits they’re not selling at that volume yet.

It would be interesting to hear what long-established cannabis entities like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) have to say about the fraction of their customers who still insist on buying products having the classic skunky smell of marijuana in comparison to those who prefer the newer, less pungent aromas.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Finds That Market Forces Are Reducing Biodiversity in Marijuana Plants

A new study on marijuana genetics reveals that the legal cannabis industry may be unintentionally reducing the plant’s genetic diversity. The push for faster-growing plants with higher cannabinoid content, mainly for economic and regulatory reasons, has led to a narrowing of the genetic pool.

The study, conducted by graduate student Caleb Y. Chen at California State Polytechnic University, Humboldt, draws from both genetic data and interviews with cannabis breeders. According to Chen, selective breeding practices in the current “post-prohibition” market are creating what he refers to as a genetic “bottleneck.”

While humans have always shaped cannabis genetics to suit their needs, recent breeding has focused narrowly on certain traits like high THC levels, a strong terpene profile, and consistency in chemical composition.

These choices may make sense in a market driven by regulation and consumer demand, but they come at a cost. In an earlier paper from 2021, Chen pointed out that many growers select high-THC strains not because they prefer them, but because state regulations and consumer expectations push them in that direction. As a result, genetic variation is being lost.

The issue isn’t exclusive to cannabis. Many crops face similar reductions in genetic variety due to selective breeding. However, cannabis seems especially vulnerable. The study highlights that what are often described as “wild” marijuana plants today are most likely just escaped domestic strains, not true wild varieties.

Natural processes like wind pollination can spread pollen from hybrid plants to local landrace strains, erasing their distinct genetic identities. This kind of contamination has been reported in countries like Thailand, Jamaica, India, and Mexico.

Chen warns that even without the history of prohibition, the cannabis plant is at risk of becoming genetically uniform. Today, only a small number of cultivars dominate the global market. These strains are treated much like other mass-produced crops, with little regard for preserving their genetic uniqueness.

He also points out that “craft marijuana,” while often used as a marketing label, represents a smaller, more diverse subculture within the industry. Some breeders and growers believe that current testing methods overlook certain compounds that contribute to the overall experience of using cannabis.

Chen’s research also touches on marketing practices, noting that commercial interests sometimes lead to misleading labels on cannabis strains. Growers may intentionally misname their products to meet consumer expectations or fit into regulatory categories.

The study concludes that modern cannabis regulations, falling product prices, and the push for higher yields are all contributing to reduced genetic diversity. It urges policymakers to recognize the importance of maintaining diverse cannabis genetics and recommends that breeders’ knowledge be taken seriously in future regulatory decisions.

It would be interesting to hear what major cannabis brands like Cresco Labs Inc. (CNX: CL) (OTCQX: CRLBF) think about concerns that marijuana genetic diversity is being sacrificed at the altar of commercial interests.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Facebook Appears to No Longer Censor Marijuana Searches

Earlier this year, Meta stated it would shift how it handles controversial topics by loosening certain content rules, particularly around issues frequently debated in politics, such as gender identity and immigration. However, when it came to cannabis, the company continued to censor search results for key terms. Instead of showing related content, users saw alerts asking them to report any drug sales.

The restriction appears to have been lifted, with searches that were previously blocked now delivering actual results and the earlier warnings no longer appear. Though many digital platforms enforce rules against selling drugs and limit who can view substance-related posts, Meta’s actions drew criticism for being too broad and silencing legitimate content meant to educate and inform.

Previously, typing in phrases like “Marijuana Policy Project” or “Massachusetts Cannabis Control Commission” on Facebook returned zero results—just a notice encouraging people to flag drug-related posts. That no longer seems to be the case. It’s unclear exactly when the policy was revised.

NORML’s political director Morgan Fox had spoken out about the impact of Meta’s restrictions saying they severely limited how advocates could reach the public. After noticing the shift in search results, he expressed hope that the changes were permanent and wouldn’t just be a short-term adjustment. He also stressed the need for Meta to implement more consistent and transparent moderation systems to avoid repeated censorship of advocacy and educational content.

Kat Murti, who leads Students for Sensible Drug Policy, welcomed the search update but pointed out that issues persist. She mentioned meeting with Meta more than a year ago to highlight concerns, including how the platform’s algorithms were limiting visibility for accounts following the law and supporting public safety.

Meta’s influence in shaping public access to information is massive, Murti said. People turn to these platforms for life-saving advice on overdose prevention, civic engagement, and drug policy reform. Yet much of this content still faces unnecessary censorship, she added.

Illustrator Brian “Box” Brown, a long-time critic of Meta’s policies, said he’s noticed some changes, too. While his posts aren’t getting flagged as frequently, the reach of some cannabis-related content still feels throttled. Brown, who once toned down his own content to avoid penalties, said he now plans to stop self-censoring and see how the platform responds.

Despite growing legalization across states, social media platforms continue to flag and restrict cannabis content, prompting many creators to look for alternative spaces to connect with their audiences.

Any positive adjustments to the policies of major social media platforms are likely to be welcomed by the marijuana industry, including entities like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) that closely observe what is happening in the U.S.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Could Hemp-Sourced THC Finally Push Congress to Act?

Congress is finally moving toward addressing laws tied to the marijuana industry after years of inaction. However, instead of expanding support—such as allowing marijuana businesses access to banking services, easing tax burdens, or opening up interstate trade—lawmakers are shifting their focus to restricting products made from hemp-derived THC.

Industry experts and lobbyists say a recent GOP-backed budget plan, introduced in the House and passed by a subcommittee, aims to outlaw products made with hemp-derived THC at the federal level. Even if the proposal doesn’t make it through Congress, it signals a turning point. Many in the industry now believe the relatively unregulated days of online sales and storefronts may be nearing an end.

According to Michael Bronstein, head of the American Trade Association for Cannabis and Hemp, it’s no longer a question of whether Congress will act, but when and how extensively.

The controversy picked up speed when Representative Andy Harris proposed a redefinition of “hemp” that would close what many view as a legal gap in the 2018 Farm Bill. Harris argues that the law has allowed for the unchecked sale of intoxicating hemp products—like delta-8 THC and THCA flower—via gas stations and websites, without oversight.

His amendment, which narrowly passed its first vote, seeks to ban high-THCA hemp flower and remove lab-created cannabinoids like delta-10 THC and THCP from the legal definition of hemp. If adopted, the change could force many hemp producers and sellers to shut down or drastically alter their businesses. Still, who would enforce such a ban and how effective it would be remains unclear.

Despite this push, Harris’ proposal faces significant challenges. Democrats are unlikely to support a bill that also includes heavy cuts to social programs. And given the narrow GOP majority in the House due to recent retirements, a bill that loses just a few Republican votes could be dead on arrival.

Moreover, states with large hemp farming industries like North Carolina and Kentucky may resist changes that could hurt their agricultural economies. Many lawmakers seem unwilling to upset the farmers and small businesses that invested heavily under the original Farm Bill.

Christopher Lackner, who leads the Hemp Beverage Alliance, said there’s confidence Congress won’t abandon the industry. He pointed out that President Trump, who signed the original Farm Bill, is still in office, which gives advocates hope.

Interestingly, Harris’ proposal has sparked unity among competing marijuana sectors. Instead of dividing hemp and marijuana stakeholders, it has brought them together in opposition. Liquor distributors, too, are backing hemp products to make up for falling alcohol sales.

Advocacy groups are now using this moment to better inform legislators about regulated hemp and the success of sensible rules in certain states. Meanwhile, many on Capitol Hill agree that the situation created by the 2018 bill needs fixing—but they’re wary of swinging the pendulum too far in the other direction.

Marijuana companies like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) from inside and outside the U.S. will be watching any decisions that federal lawmakers make on the hemp derivatives since this could have significant impacts upon the hemp and marijuana industries.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com